Unlock personalized cancer care. Book a Test Now
This is to bring to your notice that SOT Therapy from RGCC is not available in Singapore
Onconomics Extracts test is a unique test that provides precise information on the effectiveness of plants and natural extracts in treating cancer. Many patients who have cancer are simultaneously taking supplements. The test can inform the patient and the treating physician of the effectiveness of a particular extract or whether it works at all. This guide would remove a large amount of guesswork involved as well as the number of tablets that may not work in a particular case.
This comprehensive test provides an in-depth analysis, of how effective specific natural substances and plant extracts are against your cancer.
The test measures the CTC count in the blood.
The increase or decrease in count will help clinicians and patients understand the progression of cancer and treatment response.
Many natural substances are known to have cancer-treating properties, but to know which specific natural substance is effective, Onconomics Extracts is used.
With over 50+ natural substances assessed against specific cancer cells of each patient, we derive the effectiveness of each substance and prepare an individualized plan to benefit the patient.
Reserve your 30-minute free consultation
The test looks at how the extracts can stop the signals that drive cancer cells to grow and multiply.
It assesses how these extracts can boost your immune system's response by stimulating the immune system.
The test equips patients with information about how natural extracts influence the effectiveness of ongoing anti-cancer treatments.
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
Whole peripheral blood sample, Tissue for CNS primary tumors
15-25 ml blood, minimum 400 mg tissue
10-12 days in the lab
21 days after sample collection
Applicable for all cancer types
To whom it is relevant: The test is relevant for those who have exhausted chemotherapeutic options or those who want a holistic approach.
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
©2024 All Rights Reserved. Designed by Bee High Media.
